Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference
Cytek Biosciences (Nasdaq: CTKB) announced its participation in the Piper Sandler 36th Annual Healthcare Conference in New York. The company's management will engage in a fireside chat on Tuesday, December 3, 2024, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). A live and archived webcast of the presentation will be available to interested parties through the 'Investors' section of Cytek's website at investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB) ha annunciato la sua partecipazione alla 36ª Conferenza Annuale sulla Salute di Piper Sandler a New York. La direzione dell'azienda parteciperà a un colloquio informale martedì 3 dicembre 2024, alle 16:30 ora orientale (13:30 ora del Pacifico). Una webcast dal vivo e in archivio della presentazione sarà disponibile per le parti interessate nella sezione 'Investitori' del sito web di Cytek all'indirizzo investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB) anunció su participación en la 36ª Conferencia Anual de Salud de Piper Sandler en Nueva York. La dirección de la empresa participará en una charla informal el martes 3 de diciembre de 2024, a las 4:30 p.m. hora del Este (1:30 p.m. hora del Pacífico). Una transmisión en vivo y grabada de la presentación estará disponible para las partes interesadas a través de la sección 'Inversores' del sitio web de Cytek en investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB)는 뉴욕에서 열리는 파이퍼 샌들러 제36회 연례 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사의 경영진은 2024년 12월 3일 화요일 동부 표준시 기준 오후 4시 30분 (태평양 표준시 기준 오후 1시 30분)에 대화에 참여할 예정입니다. 발표의 라이브 및 아카이브된 웹캐스트는 Cytek 웹사이트의 '투자자' 섹션을 통해 관심 있는 당사자에게 제공될 예정입니다: investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB) a annoncé sa participation à la 36e Conférence Annuelle sur la Santé de Piper Sandler à New York. La direction de la société participera à une discussion informelle le mardi 3 décembre 2024, à 16h30, heure de l'Est (13h30, heure du Pacifique). Un webinaire en direct et enregistré de la présentation sera disponible pour les parties intéressées dans la section 'Investisseurs' du site web de Cytek à l'adresse investors.cytekbio.com.
Cytek Biosciences (Nasdaq: CTKB) gab seine Teilnahme an der 36. jährlichen Gesundheitskonferenz von Piper Sandler in New York bekannt. Das Management des Unternehmens wird am Dienstag, den 3. Dezember 2024, um 16:30 Uhr Eastern Time (13:30 Uhr Pacific Time) an einem informellen Gespräch teilnehmen. Ein Live- und aufgezeichnetes Webcast der Präsentation wird interessierten Parteien über den Bereich 'Investoren' auf der Website von Cytek unter investors.cytekbio.com zur Verfügung stehen.
- None.
- None.
FREMONT, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Piper Sandler 36th Annual Healthcare Conference in New York, NY.
Cytek management is scheduled to participate in a fireside chat on Tuesday, December 3, 2024, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: investors.cytekbio.com.
About Cytek Biosciences, Inc.
Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP™) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s FSP platform includes its core instruments, the Cytek Aurora™ and Northern Lights™ systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion™ reagent cocktail preparation system; the Enhanced Small Particle™ (ESP™) detection technology; the flow cytometer and imaging products under the Amnis® and Guava® brands; and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.
Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use in China and the European Union).
Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Northern Lights, Cytek Orion, Enhanced Small Particle, ESP, Amnis and Guava are trademarks of Cytek Biosciences, Inc.
In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X (formerly Twitter) account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek’s website, LinkedIn page, and X account in addition to following its SEC filings, news releases, public conference calls and webcasts.
Media Contact:
Stephanie Olsen
Lages & Associates
(949) 453-8080
stephanie@lages.com
Investor Contact:
Paul Goodson
Head of Investor Relations
Cytek Biosciences
pgoodson@cytekbio.com
FAQ
When is Cytek Biosciences (CTKB) presenting at the Piper Sandler Healthcare Conference 2024?
How can I watch Cytek Biosciences (CTKB) presentation at the Piper Sandler Conference?
What type of presentation will Cytek Biosciences (CTKB) give at the Piper Sandler Healthcare Conference?
Where is the Piper Sandler Healthcare Conference 2024 being held for Cytek Biosciences (CTKB)?
